Investors seek growth stocks for exceptional returns, but finding one can be tough due to volatility and risk. The Zacks Growth Style Score helps identify top picks like Medpace (MEDP), with a projected EPS growth of 17.1% this year. Cash flow growth is at 40.3%, and earnings estimates have been revised upwards.

Research Chief names Medpace as a Zacks Rank #1 stock with a Growth Score of A, highlighting its potential for outperformance. Meanwhile, a company targeting millennial and Gen Z audiences is identified as a top pick to double in value, generating nearly $1 billion in revenue last quarter. A recent pullback presents an ideal opportunity for investors.

From thousands of stocks, 5 Zacks experts choose their favorite to skyrocket +100% or more, with Director of Research Sheraz Mian selecting one with the most explosive upside potential. This top pick targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter. A recent pullback makes it an ideal time to jump aboard.

Read more at Nasdaq: Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why